Jasper Therapeutics, Inc. - 8-K Filing
Jasper Therapeutics acquired Kira Pharmaceuticals in a merger transaction effective July 16, 2026. (Items: 5.03 of this Current Report on Form 8-K and incorporated into this Item 1, 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2, 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3, 7.01 of this Current Report on Form 8-K, including the presentation attached as Exhibit 99)
Tickers: $JSPR